Regeneration of the pancreatic β cell

Journal of Clinical Investigation

Volumn 115, Issue 1, 2005, Pages 5-12

  Trucco, Massimo ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT HUMAN INSULIN;

AUTOIMMUNE DISEASE; CELL REGENERATION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL RESEARCH; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; ANIMAL; CLASSIFICATION; CYTOLOGY; GENE THERAPY; GENETICS; IMMUNOLOGY; PANCREAS ISLET; PATHOLOGY; PHYSIOLOGY; REGENERATION; STEM CELL;

ANIMALS; DIABETES MELLITUS, TYPE 1; GENE THERAPY; HUMANS; ISLETS OF LANGERHANS; REGENERATION; STEM CELLS;

EID: 13744261497     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200523935     Document Type: Review

References (73)

1. Wells, J.M. 2003. Genes expressed in the developing endocrine pancreas and their importance for stem cell and diabetes research. Diabetes Metab. Res. Rev. 19:191-201.
2. Jensen, J. 2004. Gene regulatory factors in pancreatic development. DCK Dyn. 229:176-200.
3. Bach, J.F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:516-542.
4. Lacy, P.E. 1982. Pancreatic transplantation as a means of insulin delivery. Diabetes Care. 5(Suppl. 1):93-97.
5. Shapiro, A.M., et al. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Eng. J. Med. 343:230-238.
6. Ryan, E.A., et al. 2001. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes. 50:710-719.
7. Steffensen, I., Dulin, M.F., Walters, E.T., and Morris, C.E. 1995. Peripheral regeneration and central sprouting of sensory neurone axons in Aplysia californica following nerve injury. J. Exp. Biol. 198:2067-2078.
8. Ramachandra, A.V., Swamy, M.S., and Kurup, A.K. 1996. Local and systemic alterations in cyclic 3′,5′ AMP phosphodiesterase activity in relation to tail regeneration under hypothyroidism and T4 replacement in the lizard, Mabuya carinata. Mol. Reprod. Dev. 45:48-51.
9. Stocum, D.L. 2002. A tail of transdifferentiation. Science. 298:1901-1903.
10. Lipsett, M., and Finegood, D.T. 2002. β-cell neogenesis during prolonged hyperglycemia in rats. Diabetes. 51:1834-1841.
11. Gu, D., Lee, M.S., Krahl, T., and Sarvetnick, N. 1994. Transitional cells in the regenerating pancreas. Development. 120:1873-1881.
12. Bernard-Kargar, C., and Ktorza, A. 2001. Endocrine pancreas plasticity under physiological and pathological conditions. Diabetes. 50(Suppl. 1):S30-S35.
13. Brelje, T.C., et al. 1993. Effect of homologous placental lactogens, prolactins, and growth hormones on islet β-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology. 132:879-887.
14. Rosenberg, L. 1995. In vivo cell transformation: neogenesis of beta cells from pancreatic ductal cells. Cell Transplant. 4:371-383.
15. Bouwens, L. 1998. Transdifferentiation versus stem cell hypothesis for the regeneration of islet beta-cells in the pancreas. Microsc. Res. Tech. 15:332-336.
16. Bonner-Weir, S., Deery, D., Leahy, J.L., and Weir, G.C. 1989. Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes. 38:49-53.
17. Arnush, M., et al. 1996. Growth factors in the regenerating pancreas of gamma-interferon transgenic mice. Lab. Invest. 74:985-990.
18. Herrera, P.L. 2000. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development. 127:2317-2322.
19. + cells are islet progenitors and are distinct from duct progenitors. Development. 129:2447-2457.
20. Weir, G.G., and Bonner-Weir, S. 2004. Beta-cell precursors - a work in progress. Nat. Biotechnol. 22:1-2.
21. Seaberg, R.M., et al. 2004. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat. Biotechnol. 22:1115-1124.
22. Suzuki, A., Nakauchi, H., and Taniguchi, H. 2004. Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes. 53:2143-2152.
23. Bonner-Wier, S., and Sharma, A. 2002. Pancreatic stem cells. J. Pathol. 197:519-526.
24. Dor, Y., Brown, J., Marinez, O.I., and Melton, D. 2004. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 429:41-46.
25. Pelengaris, S., Khan, M., and Evan, G.I. 2002. Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell. 109:321-334.
26. Sutherland, D.E., et al. 1984. Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes. Trans. Assoc. Am. Physicians. 97:80-87.
27. Ogawa, N., List, J.F., Habener, J.F., and Maki, T. 2004. Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes. 53:1700-1705.
28. Ikehara, S., et al. 1985. Prevention of type 1 diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc. Natl. Acad. Sci. U. S. A. 82:7743-7747.
29. Li, H., et al. 1996. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J. Immunol. 156:380-388.
30. Zorina, T.D., et al. 2002. Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes. Cell Transplant. 11:113-123.
31. Ryu, S., Kodama, S., Ryu, K., Schoenfeld, D.A., and Faustman, D.L. 2001. Reversal of established autoimmune diabetes by restoration of endogenous β cell function. J. Clin. Invest. 108:63-72. doi:10.1172/JCI200112335.
32. Hess, D., et al. 2003. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 21:763-770.
33. Zorina, T.D., et al. 2003. Recovery of the endogenous beta cell function in autoimmune diabetes. Stem Cells. 21:377-388.
34. Ricordi, C., et al. 1991. In vivo effect of FK506 on human pancreatic islets. Transplantation. 52:519-526.
35. Tamura, K., et al. 1995. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic β-cell. Transplantation. 59:1606-1615.
36. Bell, E., et al. 2003. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes. 52:2731-2739.
37. Paris, M., Bernard-Kargar, C., Berthault, M.F., Bouwens, L., and Ktorza, A. 2003. Specific and combined effects of insulin and glucose on functional pancreatic β-cell mass in vivo and in adult rats. Endocrinology. 144:2717-2727.
38. Farilla, L., et al. 2002. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology. 143:4397-4408.
39. Lechner, A., et al. 2004. No evidence for significant transdifferentiation of bonemarrow into pancreatic β-cells in vivo. Diabetes. 53:616-623.
40. Kodama, S., Kühtreiber, W., Fujimura, S., Dale, E.A., and Faustman, D.L. 2003. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science. 302:1223-1227.
41. Thomson, J.A., et al. 1998. Embryonic stem cell lines derived from human blastocysts. Science. 282:1145-1147.
42. Shamblott, M.J., et al. 1998. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. U. S. A. 95:13726-13731.
43. Cowan, C.A., et al. 2004. Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350:1353-1356.
44. Wagers, A.J., and Weissman, I.L. 2004. Plasticity of adult stem cells. Cell. 116:639-648.
45. Hwang, W.S., et al. 2004. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science. 303:1669-1674.
46. Lumelsky, N., et al. 2001. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science. 292:1389-1394.
47. Beattie, G.M., Rubin, J.S., Mally, M.I., Otonkoski, T., and Hayek, A. 1996. Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes. 45:1223-1228.
48. Selander, L., and Edlund, H. 2002. Nestin is expressed in mesenchymal and not epithelial cells of the developing mouse pancreas. Mech. Dev. 113:189-192.
49. Treutelaar, M.K., et al. 2003. Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes. 52:2503-2512.
50. Rajagopal, J., Anderson, W.J., Kume, S., Martinez, O.I., and Melton, D.A. 2003. Insulin staining of ES cell progeny from insulin uptake. Science. 299:363.
51. Hara, M., et al. 2003. Transgenic mice with green fluorescent protein-labeled pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 284:E177-E183.
52. Bertera, S., et al. 2003. Body window-enabled in vivo multicolor imaging of transplanted mouse islets expressing an insulin-timer fusion protein. BioTechniques. 35:718-722.
53. Lagasse, E., et al. 2000. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 6:1229-1234.
54. Weimann, J.M., Charlton, C.A., Brazelton, T.R., Hackman, R.C., and Blau, H.M. 2003. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc. Natl. Acad. Sci. U. S. A. 100:2088-2093.
55. Rose, T., et al. 2003. The role of cell type in bone healing mediated by ex vivo gene therapy. Langenbecks Arch. Surg. 388:347-355.
56. Kahn, A. 2000. Converting hepatocytes to β-cells - a new approach for diabetes? (News & Views). Nat. Med. 6:505-506.
57. Perry, D. 2000. Patients' voices: the powerful sound in stem cell debate. Science. 287:1423.
58. Wagers, A.J., Sherwood, R.L., Christensen, J.L., and Weissman, I.L. 2002. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 297:2256-2259.
59. Wang, X., et al. 2003. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 422:897-901.
60. Choi, J.B., et al. 2003. Little evidence of trans-differentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia. 46:1366-1374.
61. Alvarez-Dolado, M., et al. 2003. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 425:968-973.
62. Ianus, A., Holz, G.G., Theise, N.D., and Hussain, M.A. 2003. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest. 111:843-850. doi:10.1172/JCI200316502.
63. Cheung, A.T., et al. 2000. Glucose dependent insulin release from genetically engineered K cells. Science. 290:1959-1962.
64. Ferber, S., et al. 2000. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat. Med. 6:568-572.
65. Ber, I., et al. 2003. Functional, persistent, and extended liver to pancreas transdifferentiation. J. Biol. Chem. 278:31950-31957.
66. Drukker, M., et al. 2002. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A 99:9864-9869.
67. Li, L., et al. 2004. Human embryonic stem cells possess immune-privileged properties. Stem Cells. 22:448-456.
68. Kennedy, D. 2004. Stem cells, redux. Science. 303:1581.
69. Chatenoud, L., Primo, J., and Bach, J.-F. 1997. CD3 antibody-induced dominant self tolerance in overt autoimmunity in non-obese diabetic mice. J. Immunol. 158:2947-2954.
70. Herold, K.C., et al. 2002. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346:1692-1698.
71. Chatenoud, L. 2003. CD3-specific antibody-induced active tolerance. Nat. Rev. Immunol. 3:123-132.
72. Zheng, X.X., et al. 2003. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity. 19:503-514.
73. Machen, J., et al. 2004. Antisense oligonucleotide downregulating co-stimulation confer diabetes-preventive properties to NOD dendritic cells. J. Immunol. 173:4331-4341.